24 weeks of interferon-ribavirin therapy should not routinely be given to all hepatitis C patients
Leeuwen, Dirk J., Yee, Leland J., Langner, Rebecca G.Volume:
97
Language:
english
Journal:
The American Journal of Gastroenterology
DOI:
10.1111/j.1572-0241.2002.05512.x
Date:
February, 2002
File:
PDF, 27 KB
english, 2002